Methods such as CRISPR-Cas9 can exhibit unpredictability in both off- and on-target applications, but seqWell’s Tagify UMI tagging reagents ensure reproducibility, paving the way for the future of gene editing QC.

Writing the Future of Gene Editing QC

While genome editing tools like TALENs and ZFNs have transformed biomedical research, CRISPR-Cas9 stands out as a powerful tool since the early 2010s. The therapeutic potential of gene editing is immense, but to ensure precise edits, further research and the development of robust QC methods are essential. Transposase-based approaches, such as seqWell’s Tagify UMI reagents, offer a promising solution. Integrating Tagify UMIs with methods like UDiTaS™ can help establish QC benchmarks, contributing to the creation of safer and more effective gene editing techniques.

Ensure Consistency and Scalability

Georgia Giannoukos, Ph.D., Director of Next Generation Sequencing at Editas Medicine, emphasizes the use of seqWell’s custom Tagify reagent for UDiTaS. The consistent batches yield similar tagmentation profiles and editing results, with the flexibility to scale reactions from 96 to 384 wells. This adaptability has allowed the processing of thousands of reactions over a year, ensuring both consistency and scalability in gene editing applications.